[go: up one dir, main page]

ES465514A1 - Procedimiento para la obtencion de derivados de glucosamina. - Google Patents

Procedimiento para la obtencion de derivados de glucosamina.

Info

Publication number
ES465514A1
ES465514A1 ES465514A ES465514A ES465514A1 ES 465514 A1 ES465514 A1 ES 465514A1 ES 465514 A ES465514 A ES 465514A ES 465514 A ES465514 A ES 465514A ES 465514 A1 ES465514 A1 ES 465514A1
Authority
ES
Spain
Prior art keywords
glucosamine derivatives
procedure
increase
obtaining
obtaining glucosamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES465514A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES465514A1 publication Critical patent/ES465514A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Procedimiento para la obtención de derivados de glucosamina de fórmula general***(ver fórmula I)donde X significa un grupo carbonilo o sulfoniloR significa un resto alquiloen caso dado sustituidoo un resto arilo carbocíclicoen caso dado sustituidoo un resto arilo carbocíclicoen caso dado sustituido yen caso de que X sea el grupo carbonilotambién un resto alcoxi o bencilosiR1 significa hidrógenoalquiloo un resto bencilo en caso dado sustituidoR2 significa hidrógeno o alquilo inferiorR4 y R6 significan hidrógenoalquilo o un resto bencilo en caso dado sustituido o un resto aciloR7 significa hidrógenoalquilohidroximetilomercaptometilo o feniloR8 significa un grupo carboxilo en caso dado esterificado o amidado y R9 significa un grupo carboxiloen caso dado esterificado o amidadobajo la condición de que el resto alquilo Ren caso dado de que X signifique el grupo carbonilo.
ES465514A 1975-12-10 1977-12-28 Procedimiento para la obtencion de derivados de glucosamina. Expired ES465514A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1604275A CH613709A5 (en) 1975-12-10 1975-12-10 Process for the preparation of glucosamine derivatives

Publications (1)

Publication Number Publication Date
ES465514A1 true ES465514A1 (es) 1978-09-16

Family

ID=4414012

Family Applications (2)

Application Number Title Priority Date Filing Date
ES454118A Expired ES454118A1 (es) 1975-12-10 1976-12-10 Procedimiento para la obtencion de derivados de flucosamina.
ES465514A Expired ES465514A1 (es) 1975-12-10 1977-12-28 Procedimiento para la obtencion de derivados de glucosamina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES454118A Expired ES454118A1 (es) 1975-12-10 1976-12-10 Procedimiento para la obtencion de derivados de flucosamina.

Country Status (30)

Country Link
JP (1) JPS5273820A (es)
AR (2) AR224091A1 (es)
AT (1) AT365607B (es)
AU (1) AU508764B2 (es)
BE (1) BE849214A (es)
CA (1) CA1262400A (es)
CH (2) CH613709A5 (es)
CS (4) CS205026B2 (es)
DD (1) DD129781A5 (es)
DE (1) DE2655500A1 (es)
DK (1) DK154654C (es)
ES (2) ES454118A1 (es)
FI (1) FI64164C (es)
FR (1) FR2361902A1 (es)
GB (1) GB1570625A (es)
GR (1) GR61647B (es)
HK (1) HK32883A (es)
HU (1) HU177970B (es)
IE (1) IE44190B1 (es)
IL (1) IL51076A (es)
MY (1) MY8400123A (es)
NL (1) NL7613666A (es)
NO (1) NO144850C (es)
NZ (1) NZ182837A (es)
PL (4) PL110794B1 (es)
PT (1) PT65946B (es)
SE (1) SE445923B (es)
SG (1) SG11083G (es)
SU (3) SU660589A3 (es)
ZA (1) ZA767333B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4370265A (en) * 1974-10-22 1983-01-25 Agence Nationale De Valorisation Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
CH636887A5 (en) * 1976-04-26 1983-06-30 Syntex Inc Process for the preparation of novel immunological adjuvant compounds
EP0002677B1 (en) 1977-12-02 1982-10-13 Takeda Chemical Industries, Ltd. Glucosamine-peptide derivatives and their pharmaceutical compositions
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
EP0003833B2 (de) * 1978-02-24 1990-12-19 Ciba-Geigy Ag Antigenderivate, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
FR2420545A1 (fr) * 1978-03-20 1979-10-19 Anvar Nouveaux esters de l'acide n-acetyl-muramyl-aminoacyl-glutamique ou des derives de substitution de celui-ci a proprietes anti-infectieuses et/ou d'adjuvants immunologiques
FR2428050A1 (fr) * 1978-06-05 1980-01-04 Anvar Oligomeres de composes du type muramyl-peptide et medicaments les contenant
FR2428051A1 (fr) * 1978-06-05 1980-01-04 Anvar Nouveaux composes du type muramyl-peptide et medicaments les contenant
FR2446292A1 (fr) * 1979-01-12 1980-08-08 Anvar Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant
US4256735A (en) * 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
FR2449697A1 (fr) 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
FI75578C (fi) 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
JPS5649396A (en) * 1979-09-28 1981-05-02 Dai Ichi Seiyaku Co Ltd Novel muramyldipeptide derivative
DE3070457D1 (en) * 1979-10-02 1985-05-15 Ciba Geigy Ag Combinatory compositions for use in a method for enhancing the activity of antibiotics, antibiotic preparations having enhanced activity and process for their production
US4409209A (en) * 1979-10-12 1983-10-11 Ciba-Geigy Corporation Novel phosphorylmuramyl peptides and processes for the manufacture thereof
FI803077A7 (fi) 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
US4310514A (en) 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
EP0056560A1 (de) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika
GR78246B (es) * 1981-01-23 1984-09-26 Ciba Geigy Ag
JPS6042398A (ja) * 1983-08-18 1985-03-06 Toshiyuki Hamaoka ムラミルジペプチド活性エステル誘導体
EP0541486A1 (de) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
RU2181729C1 (ru) * 2000-09-20 2002-04-27 Калюжин Олег Витальевич Производные мурамовой кислоты
JP4875612B2 (ja) 2005-04-27 2012-02-15 真司 武岡 カチオン性アミノ酸型脂質
US10610564B2 (en) 2015-02-26 2020-04-07 Stc.Unm IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
US12134664B2 (en) 2015-12-10 2024-11-05 Bharat Biotech International Ltd. Muramyl peptide derivatives
CN108884132B (zh) * 2015-12-10 2022-10-04 巴拉特生物技术国际有限公司 胞壁酰肽衍生物化合物、其合成及其用途
EP3389643B1 (en) * 2015-12-15 2023-05-03 Bharat Biotech International Limited Novel muramyl peptide derivative compound, synthesis and uses thereof
MX2020002010A (es) 2017-08-21 2020-07-13 Celgene Corp Procesos para la preparacion de 4,5-diamino-5-oxopentanoato de (s)-terc-butilo.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

Also Published As

Publication number Publication date
PL194291A1 (pl) 1978-10-23
FR2361902A1 (fr) 1978-03-17
AU508764B2 (en) 1980-04-03
IE44190L (en) 1977-06-10
ATA909276A (de) 1981-06-15
FI763541A7 (es) 1977-06-11
FI64164C (fi) 1983-10-10
SU660589A3 (ru) 1979-04-30
AT365607B (de) 1982-02-10
NO144850C (no) 1981-11-25
NO144850B (no) 1981-08-17
MY8400123A (en) 1984-12-31
HK32883A (en) 1983-09-02
NZ182837A (en) 1978-07-28
HU177970B (en) 1982-02-28
FI64164B (fi) 1983-06-30
CH613709A5 (en) 1979-10-15
BE849214A (fr) 1977-06-09
ES454118A1 (es) 1978-03-01
SE7613851L (sv) 1977-06-11
SE445923B (sv) 1986-07-28
SU747430A3 (ru) 1980-07-23
NL7613666A (nl) 1977-06-14
AR220686A1 (es) 1980-11-28
PT65946B (en) 1978-06-14
NO764191L (es) 1977-06-13
PL112672B1 (en) 1980-10-31
IL51076A (en) 1980-09-16
DK552476A (da) 1977-06-11
ZA767333B (en) 1977-11-30
SG11083G (en) 1983-09-16
DK154654C (da) 1989-05-08
FR2361902B1 (es) 1980-11-07
GB1570625A (en) 1980-07-02
GR61647B (en) 1978-12-05
PL110787B1 (en) 1980-07-31
DD129781A5 (de) 1978-02-08
DE2655500A1 (de) 1977-06-23
AR224091A1 (es) 1981-10-30
SU1060118A3 (ru) 1983-12-07
PT65946A (en) 1977-01-01
IL51076A0 (en) 1977-02-28
CS205028B2 (en) 1981-04-30
CH614718A5 (en) 1979-12-14
JPS5273820A (en) 1977-06-21
PL110794B1 (en) 1980-07-31
DK154654B (da) 1988-12-05
IE44190B1 (en) 1981-09-09
CS205026B2 (en) 1981-04-30
CS205027B2 (en) 1981-04-30
JPS638118B2 (es) 1988-02-19
CS205025B2 (en) 1981-04-30
PL110353B1 (en) 1980-07-31
AU2042276A (en) 1978-06-15
DE2655500C2 (es) 1988-12-22
CA1262400A (en) 1989-10-17

Similar Documents

Publication Publication Date Title
ES465514A1 (es) Procedimiento para la obtencion de derivados de glucosamina.
ATE116993T1 (de) Saponin-hilfsmittel.
DE69331901D1 (de) Impfstoff auf urease-basis gegen helicobacter infektionen
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
MX9301706A (es) Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
ATE326231T1 (de) Mutierendes enterotoxin als nichttoxisches orales adjuvans
ES8203226A1 (es) Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.
SE8402551L (sv) Cinnamoylmoranolin-derivat
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe
SE7511794L (sv) Fergemne
ES379641A1 (es) Procedimiento de produccion de antigenos inactivos para preparados farmaceuticos.
GB1256457A (en) Diethylaminoethyldextran (deae-d) as adjuvant for vaccines for active immunisation
DK313587D0 (da) Tetrahydrobenzothiazolforbindelser, deres fremstilling og anvendelse
GR33644B (el) Μεθοδος δια την παρασκευην νεων αλογονουποκατεστημενων τετραυδρο-κιναζολινων.
NO913131L (no) Immunogene konjugater av ikke-toksisk oligosakkarid fra bordetella pertussis lipoolysakkarid.
BG31229A3 (bg) Метод за получаване на n-(5-тетразолил)-1-оксо-1н-6-алкоксипиримидо(1,2-а)- хинолин-2-карбоксамиди
BG33280A3 (bg) Метод за получаване на (2, 2- диметил- 1, 2- хидрохинолин- 4- ил)- метилсулфонова киселина и нейни соли
ATE18007T1 (de) Hepatitisimpfstoff.
AU1002983A (en) Substituted 1-benzoyl-2-phenyliminoimidazolines
DK0459176T3 (da) Oligophosphater med antiviral virkning
ES266270A1 (es) Procedimiento para preparar vacunas poliomieliticas
JPS51125728A (en) Novel non-medical germicides and their preparation
FR2287912A1 (fr) Derives de polysaccharide portant des groupements amines, leurs procedes de preparation et leurs applications en tant qu'agents adjuvants de l'immunite non specifique
Boyett Milo stover as an energy source for growing beef heifers and lambs
GR25079B (el) Μεθοδος δια την παρασκευην ενωσεων της καρβαζολικης σειρας.